| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |